H.R. 8399
Referred to CommitteeEnd Taxpayer Subsidies for Drug Ads Act
Introduced 9/25/2020•116th Congress•House
Latest Action
Referred to the House Committee on Ways and Means.
9/25/2020 • House
Summary
End Taxpayer Subsidies for Drug Ads Act
This bill prohibits tax deductions for expenses relating to direct-to-consumer advertising of prescription drugs.
Direct-to-consumer advertising is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is (1) in regard to the drug product, and (2) primarily targeted to the general public.
Introduced in House • 9/25/2020
Enter your district to see how this bill affects your community
Topics & Subjects
Policy Area: Taxation
Business expensesIncome tax deductionsMarketing and advertisingPrescription drugs
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (3)
Party Breakdown
3
Democrats
0
Republicans
0
Independents
Sponsor
R[
Cosponsors (2)
R[
R[
Bill Journey
Originated in the House
Introduced
September 25, 2020
Referred to the House Committee on Ways and Means.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Introduced in House9/25/2020